It’s no secret that the only cannabis available for official use on research is provided by the University of Mississippi and NIDA, which is notoriously low in quality. The lawsuit also states that this marijuana is unfit for research because of “poor quality, unstable supply, and limited variability that in no way emulates the types of cannabis currently available through either state-regulated markets or informal markets where regulated supply is unavailable.” What makes it worse is that this cannabis is only allowed for research and not to be sold commercially, which means that it can’t be used for Phase 3 studies of the FDA, required under the Good Manufacturing Processes.
The new cannabis beverage boom isn’t really about replacing booze. It’s about replacing everything people…
Amber Senter co-founded Supernova Women, the organization that helped shape America’s first cannabis social equity…
The finding: states that legalized medical or recreational marijuana saw significant reductions in non-fatal opioid…
Eighty-eight percent. Let that sit for a moment. According to the latest nationwide polling from…
A story that once sounded like peak internet fantasy has taken a very real turn. …
Your June 2026 horoscopes brings a powerful mix of growth, reflection, and fresh opportunities. The…